Product Licensing

September 5, 2024

Medications En Route To Take On Obesity Epidemic

Detailed Evaluation Of Current And Future Anti-obesity Drugs Pmc Tesofensine is a presynaptic inhibitor of norepinephrine, dopamine, and serotonin initially created for the therapy of Parkinson's disease. Although its effectiveness was limited for this application, research study topics were kept...

Read more →
September 5, 2024

Healthcare Complimentary Full-text Medicinal Support For The Therapy Of Excessive Weight Present And Future

Tesofensine, An Unique Antiobesity Medication, Silences Gabaergic Hypothalamic Neurons Pmc The "dark side" model of compulsive consuming suggests that overconsumption of tasty food downregulates mesolimbic dopaminergic benefit wiring, a within-system opponent-process adaptation. Food-deprived...

Read more →
September 5, 2024

Twin- And Triple-acting Representatives For Dealing With Core And Co-morbid Signs And Symptoms Of Significant Depression: Novel Principles, New Drugs

Tesofensine, A Novel Antiobesity Medication, Silences Gabaergic Hypothalamic Neurons Pmc Tesofensine reveals promise in motivating weight reduction by reducing hunger and enhancing metabolic process. Our team provides tesofensine with an approach that involves close tracking and advice as we stay...

Read more →
September 5, 2024

Understanding New Weight-loss Medicines

What To Understand About New Weight Loss Medicines The company that makes it, Vivus, has a program to assist with your out-of-pocket costs. The retail price for Contrave ranges from concerning $700-$ 800 for a 1-month supply, depending on your drug store. The firm that makes it, Currax, has a...

Read more →
September 5, 2024

Tesofensine Treatment Accomplish Weight Management Success

Clinical Weight Management In Hoboken, Nj Shedding extra pounds can improve physical health and wellness, decrease the danger of chronic illness, increase power degrees, improve mobility, and grow a much more favorable self-image. Posner acknowledges that CNS-based weight problems medicines might...

Read more →
Welcome to MediQuest Pharmaceuticals, where innovation meets excellence in the pharmaceutical industry. I am Michael Johnson, the founder and driving force behind MediQuest Pharmaceuticals. With over two decades of experience in drug development and pharmaceutical regulations, I have dedicated my career to advancing healthcare through innovative pharmaceutical solutions. Born and raised in the bustling city of Boston, my fascination with science began at a young age, nurtured by countless hours spent in the local library reading about chemistry and biology. This passion led me to pursue a degree in Medicinal Chemistry at the University of Massachusetts, followed by a Ph.D. in Pharmaceutical Sciences. After completing my education, I ventured into the pharmaceutical industry, where I gained extensive experience in various facets of drug development and manufacturing.